NASDAQ: COEPCoeptis Therapeutics Holdings Inc Stock Ownership - Who owns Coeptis Therapeutics Holdings?
Insider buying vs selling
Have Coeptis Therapeutics Holdings Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when COEP insiders and whales buy or sell their stock.
COEP Shareholders
What type of owners hold Coeptis Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Chris Calise | 95.05% | 3,339,897 | $27.92M | Insider |
| David Mehalick | 79.19% | 2,782,615 | $23.26M | Insider |
| Robert Striar | 53.36% | 1,875,000 | $15.68M | Insider |
| Bull Horn Holdings Sponsor LLC | 53.36% | 1,875,000 | $15.68M | Insider |
| Daniel Alexander Yerace | 30.49% | 1,071,455 | $8.96M | Insider |
| Christine Elise Sheehy | 28.76% | 1,010,605 | $8.45M | Insider |
| Barclays PLC | 27.89% | 979,975 | $8.19M | Insider |
| Glazer Capital LLC | 27.45% | 964,422 | $8.06M | Insider |
| Harraden Circle Investments LLC | 14.64% | 514,436 | $4.30M | Insider |
| Gene Salkind | 8.20% | 288,102 | $2.41M | Insider |
COEP vs Biotech Stocks
Coeptis Therapeutics Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.